DrugPatentWatch Database Preview
Prinston Inc Company Profile
What is the competitive landscape for PRINSTON INC, and what generic and branded alternatives to PRINSTON INC drugs are available?
PRINSTON INC has fifty-eight approved drugs.
There are two tentative approvals on PRINSTON INC drugs.
Summary for Prinston Inc
| US Patents: | 0 |
| Tradenames: | 49 |
| Ingredients: | 49 |
| NDAs: | 58 |
Drugs and US Patents for Prinston Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 202533-002 | Jul 20, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | TELMISARTAN | telmisartan | TABLET;ORAL | 207882-002 | May 3, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208880-001 | Sep 10, 2018 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 040622-002 | Jul 18, 2006 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Prinston Inc | FENOFIBRATE | fenofibrate | TABLET;ORAL | 211080-001 | Aug 28, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
